NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $606,474 | +6.3% | 5,954 | +5.3% | 0.18% | +8.5% |
| Q2 2023 | $570,545 | +9.7% | 5,654 | 0.0% | 0.16% | +1.9% |
| Q1 2023 | $520,168 | +1.0% | 5,654 | -0.4% | 0.16% | -6.9% |
| Q4 2022 | $515,199 | +14.0% | 5,679 | -4.5% | 0.17% | 0.0% |
| Q3 2022 | $452,000 | -1.1% | 5,945 | +10.0% | 0.17% | -1.7% |
| Q2 2022 | $457,000 | -3.6% | 5,404 | 0.0% | 0.18% | +11.3% |
| Q1 2022 | $474,000 | +5.3% | 5,404 | +5.1% | 0.16% | +6.7% |
| Q4 2021 | $450,000 | +6.9% | 5,144 | 0.0% | 0.15% | -4.5% |
| Q3 2021 | $421,000 | -10.2% | 5,144 | 0.0% | 0.16% | -13.3% |
| Q2 2021 | $469,000 | +6.6% | 5,144 | 0.0% | 0.18% | -2.2% |
| Q1 2021 | $440,000 | -9.5% | 5,144 | 0.0% | 0.18% | -17.5% |
| Q4 2020 | $486,000 | +8.7% | 5,144 | 0.0% | 0.22% | -2.6% |
| Q3 2020 | $447,000 | -0.4% | 5,144 | 0.0% | 0.23% | -10.2% |
| Q2 2020 | $449,000 | +35.2% | 5,144 | +27.8% | 0.26% | -0.4% |
| Q1 2020 | $332,000 | -5.4% | 4,024 | +8.6% | 0.26% | +15.8% |
| Q4 2019 | $351,000 | +9.0% | 3,704 | 0.0% | 0.22% | +1.4% |
| Q3 2019 | $322,000 | -4.7% | 3,704 | 0.0% | 0.22% | -6.0% |
| Q2 2019 | $338,000 | -11.1% | 3,704 | -6.3% | 0.23% | -12.5% |
| Q1 2019 | $380,000 | +57.0% | 3,955 | +40.0% | 0.26% | +36.6% |
| Q4 2018 | $242,000 | +3.4% | 2,824 | +4.1% | 0.19% | +22.8% |
| Q3 2018 | $234,000 | +14.1% | 2,714 | 0.0% | 0.16% | +9.0% |
| Q2 2018 | $205,000 | -6.4% | 2,714 | 0.0% | 0.14% | -7.6% |
| Q1 2018 | $219,000 | -3.9% | 2,714 | 0.0% | 0.16% | -0.6% |
| Q4 2017 | $228,000 | -2.1% | 2,714 | 0.0% | 0.16% | -8.1% |
| Q3 2017 | $233,000 | +2.6% | 2,714 | 0.0% | 0.17% | 0.0% |
| Q2 2017 | $227,000 | +12.4% | 2,714 | 0.0% | 0.17% | +8.9% |
| Q1 2017 | $202,000 | -5.6% | 2,714 | -7.5% | 0.16% | -8.7% |
| Q4 2016 | $214,000 | -7.8% | 2,935 | 0.0% | 0.17% | -14.8% |
| Q3 2016 | $232,000 | -4.1% | 2,935 | 0.0% | 0.20% | -7.3% |
| Q2 2016 | $242,000 | +8.5% | 2,935 | -4.7% | 0.22% | +1.9% |
| Q1 2016 | $223,000 | -18.9% | 3,081 | -3.4% | 0.22% | -21.2% |
| Q4 2015 | $275,000 | -4.8% | 3,191 | +1.6% | 0.27% | -8.4% |
| Q3 2015 | $289,000 | -3.3% | 3,141 | +3.3% | 0.30% | +8.4% |
| Q2 2015 | $299,000 | -0.3% | 3,041 | 0.0% | 0.28% | +0.7% |
| Q1 2015 | $300,000 | +6.4% | 3,041 | 0.0% | 0.27% | +4.6% |
| Q4 2014 | $282,000 | – | 3,041 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |